Articles by Disease (Breast Cancer)

RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology

Journal: Current Drug Discovery Technologies
Volume: 5
Page: 263-268
Author(s): Kosei Ando, Kanji Mori, Francoise Redini and Dominique Heymann

Commercial Availability of Alpha-Emitting Radionuclides for Medicine

Journal: Current Radiopharmaceuticals
Volume: 1
Page: 127-134
Author(s): Darrell R. Fisher

Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

Journal: Current Radiopharmaceuticals
Volume: 1
Page: 203-208
Author(s): Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen

Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells

Journal: Current Radiopharmaceuticals
Volume: 1
Page: 225-233
Author(s): J. Carlsson, A. C. Steffen, A. L. Sundberg, M. Vikstrom, A. Orlova, L. Gedda, B. Stenerlow, H. Lundqvist and V. Tolmachev

Radioimmunotherapy of Infection with 213Bi-Labeled Antibodies

Journal: Current Radiopharmaceuticals
Volume: 1
Page: 234-239
Author(s): Ekaterina Dadachova

Targeted α-Particle Therapy: A Clinical Overview

Journal: Current Radiopharmaceuticals
Volume: 1
Page: 251-253
Author(s): Massimo Salvatori, Luca Indovina and Luigi Mansi

The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 6
Page: 150-159
Author(s): R. A. Wilke, R. K. Mareedu and J. H. Moore